Back

Inflammatory biomarkers suPAR, IL-6, and hsCRP and 13-year risk of mortality and MACE in type 2 diabetes: a prospective cohort study

30 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic diseases (2) Diabetes and the Heart ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hashmat Sayed Zohori Bahrami

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

5 More presentations in this session

Presentation thumbnail
The underestimated risk of prediabetes on cardiovascular and renal outcomes in patients with heart failure
Doctor A. Hammer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Microvascular endothelial function predicts incident diabetes mellitus: the ELSA-Brasil cohort study
Doctor L. Brant (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
The Relationship Between High-Sensitivity CRP and Cardiac Function in Patients with Type 2 Diabetes: A Cardiac Magnetic Resonance Study
Doctor A. Bojer (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
AI-enabled opportunistic measurement of liver steatosis in coronary artery calcium scans predicts cardiovascular events and mortality: an AI-CVD study
Doctor M. Naghavi (Houston, US)
Abstract Slides Video
Presentation thumbnail
Time for cardiologists to focus on prediabetes: challenges in risk factor control
Assistant Professor V. Medovchshikov (Aktobe, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiometabolic diseases (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Interleukin-6 and suPAR improves prediction of all-cause mortality in type 1 diabetes - the Thousand & 1 Study
thumbnail
Congress Presentation
Inflammatory biomarkers and long-term outcome in young stable patients 3 months after a first myocardial infarction
thumbnail
Congress Session
Markers of inflammation and outcomes in patients with acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources